Home> Products> nilotinib 150mg chronic myeloid leukemia treatment

{ "products": [ { "_id": "69d8d9f47c7c4d696c414270", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Nilotinib 200mg", "description": "NILOTHERAPY 200 is a targeted anti-cancer medication containing Nilotinib 200 mg, primarily used in the treatment of chronic myeloid leukemia (CML). It belongs to a class of medicines known as tyrosine kinase inhibitors (TKIs), which work by blocking the abnormal proteins responsible for cancer cell growth.\n\nDeveloped to provide more precise and effective cancer treatment, NILOTHERAPY 200 offers improved outcomes compared to traditional therapies. It is commonly prescribed for patients who are newly diagnosed with CML or those who have not responded well to other treatments.\n\nWhat is Nilotinib and How Does It Work?\n\nNilotinib is a second-generation tyrosine kinase inhibitor that specifically targets the BCR-ABL protein, a key driver of leukemia cell growth.\n\nMechanism of Action\nBlocks abnormal signals that promote cancer cell multiplication\nStops the growth and spread of leukemia cells\nHelps restore normal blood cell production\n\nUnlike chemotherapy, which affects both healthy and cancerous cells, Nilotinib works in a targeted manner, reducing damage to normal cells and improving treatment tolerability.\n\nUses of NILOTHERAPY 200\n1. Treatment of Chronic Myeloid Leukemia (CML)\n\nNILOTHERAPY 200 is widely used for:\n\nNewly diagnosed Philadelphia chromosome-positive CML\nChronic phase and accelerated phase CML\nPatients resistant or intolerant to prior therapies\n2. Long-Term Disease Control\n\nIt helps maintain remission and prevents disease progression when taken regularly as prescribed.\n\n3. Alternative to First-Line Therapies\n\nFor patients who do not respond well to other medications, NILOTHERAPY 200 serves as an effective alternative.\n\nKey Benefits of NILOTHERAPY 200\n1. Targeted Cancer Therapy\n\nNILOTHERAPY 200 specifically attacks cancer cells without extensively harming healthy cells, making it more precise than conventional chemotherapy.\n\n2. High Effectiveness in CML Management\n\nClinical studies have shown that Nilotinib provides:\n\nFaster molecular response\nImproved long-term survival rates\nReduced risk of disease progression\n3. Oral Convenience\n\nThe capsule form allows patients to take the medication at home, avoiding frequent hospital visits.\n\n4. Improved Quality of Life\n\nPatients often experience fewer severe side effects compared to traditional treatments, enabling better daily functioning.\n\n5. Suitable for Resistant Cases\n\nEffective in patients who have developed resistance to earlier therapies like imatinib.\n\nDosage and Administration\nTypically taken twice daily, approximately 12 hours apart\nMust be taken on an empty stomach (avoid food 2 hours before and 1 hour after)\nSwallow capsules whole with water\nFollow your doctor’s exact dosage instructions\nImportant Tip\n\nDo not skip doses or stop treatment without medical advice, as this may affect treatment outcomes.\n\nPossible Side Effects of NILOTHERAPY 200\n\nLike all medications, NILOTHERAPY 200 may cause side effects. While many are manageable, some require immediate attention.\n\nCommon Side Effects\nHeadache\nNausea\nFatigue\nConstipation or diarrhea\nMuscle or joint pain\nSerious Side Effects\nHeart rhythm problems (QT prolongation)\nLiver function abnormalities\nPancreatitis\nLow blood cell counts\nSudden weight gain or swelling\nWhen to Seek Medical Help\n\nContact your doctor immediately if you experience:\n\nIrregular heartbeat\nSevere abdominal pain\nYellowing of skin or eyes\nUnusual bleeding or bruising\nPrecautions and Warnings\n\nBefore starting NILOTHERAPY 200, consider the following:\n\nInform your doctor if you have heart disease, liver problems, or electrolyte imbalance\nRegular ECG monitoring may be required\nAvoid grapefruit and grapefruit juice during treatment\nNot recommended during pregnancy unless prescribed\nUse effective contraception during treatment\nDrug Interactions\n\nNilotinib may interact with:\n\nAntifungal medications\nAntibiotics\nHeart rhythm drugs\nAntacids\n\nAlways inform your healthcare provider about all medicines and supplements you are taking.\n\nStorage Instructions\nStore below 30°C in a dry place\nKeep away from moisture and direct sunlight\nKeep out of reach of children\nWhy Choose NILOTHERAPY 200?\n\nNilotherapy 200 stands out due to the following:\n\nAdvanced targeted therapy mechanism\nProven success in treating CML\nConvenient oral dosage\nEffective in resistant and intolerant cases\nTrusted pharmaceutical quality\nConclusion\n\nNILOTHERAPY 200 (Nilotinib 200 mg Capsules) is a powerful and reliable treatment option for patients with chronic myeloid leukemia. Its targeted mechanism, high effectiveness, and convenient oral administration make it a preferred choice among healthcare professionals.", "price": 3570.0, "discountamount": 1071.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2374, "imageuri": "https://productimages.withfloats.com/actual/69d8d9fb0f2d50aed157389c.png", "tileimageuri": "https://productimages.withfloats.com/tile/69d8d9fb0f2d50aed157389c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-04-10T11:07:32.379Z", "updatedon": "2026-05-26T06:50:48.256Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nilotinib-200mg/2374", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NILOTHERAPY 200", "category": "Oncology", "tags": [ "nilotinib 200mg", "nilotinib 200mg price", "tab nilotinib 200mg", "nilotinib 200mg price in india", "nilotinib 200mg in hindi", "nilotinib 200mg tab", "nilotinib 200mg side effects", "nilotinib 200mg brands in india", "nilotinib 200mg uses", "nilotinib 200mg price online", "nilotinib 200mg generic vs branded price comparison0", "is nilotinib 200mg available without prescription India", "nilotinib 200mg lead time suppliers India", "nilotinib 200mg vs imatinib price India", "nilotinib 200mg exporters from India", "nilotinib 200mg global suppliers GMP WHO certified", "nilotinib 200mg hospital procurement price India", "Buy Nilotinib 200mg Capsules Online", "Nilotinib 200mg Anti Cancer Medicine", "Nilotinib 200mg Prescription Medicine", "Nilotinib 200mg Product Image", "Best Leukemia Treatment Medicine Nilotinib", "Nilotinib Capsules for Blood Cancer Treatment", "Nilotinib 200mg Oncology Medicine", "Targeted Cancer Therapy Capsules", "Nilotinib 200mg Chemotherapy Support Medicine" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6943af86161ad9de85f42b10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "imatinib 400mg", "description": "IMATIFLOW 400, containing Imatinib IP 400mg, represents a breakthrough in targeted cancer therapy, offering patients a precise weapon against specific malignancies. This oral medication belongs to the class of tyrosine kinase inhibitors, revolutionizing treatment for conditions once deemed challenging to manage. By blocking abnormal proteins that fuel cancer cell growth, IMATIFLOW 400 helps restore normal cellular function and improves quality of life for many users.​\n\nProduct Overview\nIMATIFLOW 400 is a branded formulation of Imatinib mesylate 400mg, produced to high pharmaceutical standards for consistent efficacy and bioavailability. Each tablet delivers the active ingredient in a film-coated form, designed for once-daily administration with food to enhance absorption and minimize gastrointestinal upset. Developed for adult patients, it targets cancers driven by dysregulated tyrosine kinases like BCR-ABL, c-KIT, and PDGFR, making it a cornerstone in modern oncology protocols.​\n\nThe medication's mechanism hinges on competitive inhibition at the ATP-binding site of these kinases, halting downstream signaling pathways that promote uncontrolled proliferation, survival, and metastasis of malignant cells. Unlike traditional chemotherapy, which broadly attacks dividing cells, IMATIFLOW 400 spares most healthy tissues, leading to a more favorable safety profile. Clinical data from pivotal trials underscore its role as first-line therapy, with high response rates observed within months of initiation.​\n\nPrimary Uses\nIMATIFLOW 400 excels in treating chronic myeloid leukemia (CML), particularly in the chronic phase where it induces deep molecular responses in over 80% of patients. It suppresses the Philadelphia chromosome-positive cells hallmark of CML by inhibiting the BCR-ABL fusion protein, dramatically extending progression-free survival. For newly diagnosed patients, standard dosing starts at 400mg daily, often achieving complete cytogenetic remission.​\n\nIn gastrointestinal stromal tumors (GIST), IMATIFLOW 400 targets KIT or PDGFRA mutations, shrinking unresectable tumors and delaying progression in advanced cases. The recommended dose remains 400mg once daily, with potential escalation to 600-800mg for resistant strains, as per oncology guidelines. It also finds application in dermatofibrosarcoma protuberans (DFSP), aggressive systemic mastocytosis, and certain myelodysplastic syndromes, broadening its utility in precision medicine.​\n\nHealthcare providers monitor response via PCR for BCR-ABL transcripts in CML or imaging for GIST, adjusting therapy based on milestones like major molecular response. Patients with Ph+ acute lymphoblastic leukemia (ALL) may receive it adjunctively, enhancing outcomes when combined with chemotherapy. Overall, IMATIFLOW 400 transforms these diseases from fatal to chronically manageable.​\n\nKey Benefits\nOne standout benefit of IMATIFLOW 400 is its oral convenience, eliminating the need for frequent hospital visits associated with infusions. Response rates exceed 90% in early CML, with many patients achieving treatment-free remission after sustained deep responses, a paradigm shift from interferon-era therapies.​\n\nTumor control in GIST prevents life-threatening complications like bowel obstruction, improving survival from months to years. Its specificity reduces severe toxicities, allowing patients to maintain daily activities, work, and social engagements with minimal disruption. Long-term studies report 10-year survival rates above 80% in CML, underscoring durable efficacy.​\n\nAdditional advantages include cost-effectiveness over biologics and compatibility with supportive care like hydroxyurea for cytoreduction. Fluid retention, while common, responds well to diuretics, preserving cardiac function. For Indian patients, accessible pricing via brands like IMATIFLOW 400 supports equitable care in resource-limited settings.​\n\nPotential Side Effects\nWhile generally well-tolerated, IMATIFLOW 400 can cause edema (swelling in legs or face) in up to 70% of users, managed by dose reduction or supportive measures. Gastrointestinal issues like nausea, vomiting, and diarrhea affect 40-50%, often resolving with antiemetics and dietary adjustments.​\n\nMusculoskeletal pain, cramps, and fatigue occur frequently, alongside rash and abdominal discomfort. Hematologic effects include neutropenia or thrombocytopenia, necessitating regular blood counts. Rare but serious risks involve liver enzyme elevation, heart failure, or hemorrhage; prompt reporting of symptoms like shortness of breath or yellowing skin is crucial.​\n\nAvoid grapefruit juice, as it elevates drug levels, and inform doctors of concurrent medications like CYP3A4 inhibitors. Pregnancy category D status advises contraception, with monitoring for growth retardation in exposed fetuses. Dizziness may impair driving, so caution is essential during initial weeks.​\n\nDosage and Administration Guidelines\nSwallow IMATIFLOW 400 whole with a meal and full glass of water to optimize pharmacokinetics and reduce esophageal irritation. The standard adult dose for CML chronic phase is 400mg daily; for accelerated phase or blast crisis, 600mg. GIST dosing mirrors 400mg, titrated based on tolerance and response.​\n\nRenal or hepatic impairment requires dose adjustments—reduce to 300-400mg in moderate cases. Do not crush or chew tablets. Missed doses should be taken promptly unless near the next, avoiding doubles. Long-term use demands quarterly monitoring of CBC, liver function, and ECG.​\n\nPrecautions and Interactions\nPatients with a cardiac history need baseline echocardiograms, as QT prolongation or effusion risks exist. Drug interactions abound: St. John's wort induces metabolism, reducing efficacy; ketoconazole boosts levels. Vaccines, especially live ones, are contraindicated during therapy.​\n\nRegular dermatologic checks mitigate skin cancer risk from prolonged use. Hydration combats fluid retention, and low-salt diets aid management. Steris Healthcare emphasizes patient education via counseling on adherence for optimal outcomes.​\n\nConclusion\nIMATIFLOW 400 (Imatinib IP 400mg) stands as a testament to targeted therapy's power, offering robust control over CML, GIST, and related cancers with a balance of efficacy and manageability. Its benefits in prolonging life and enhancing daily functioning far outweigh transient side effects for most when monitored diligently. Consult oncologists for personalized plans, ensuring this innovative treatment maximizes hope and health in the fight against cancer.", "price": 1827.0, "discountamount": 540.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2249, "imageuri": "https://productimages.withfloats.com/actual/6943b026ca1b0dcfc6c37820.png", "tileimageuri": "https://productimages.withfloats.com/tile/6943b026ca1b0dcfc6c37820.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-18T07:38:46.766Z", "updatedon": "2026-04-15T10:27:12.329Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//imatinib-400mg/2249", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IMATIFLOW 400", "category": "NEPHROLOGYRANGE", "tags": [ "Imatinib IP 400mg", "offering robust control over CML.", "related cancers with a balance of efficacy and manageability.", "innovative treatment maximizes hope and health in the fight against cancer.", "cancer therapy.", "fuel cancer cell growth.", "chemotherapy.", "imatinib 400mg.", "imatinib 400mg tablet.", "tab. imatinib 400mg.", "imatinib 400mg price.", "imatinib 400mg tab", "imatinib 400mg side effects.", "imatinib 400 mg tablet", "imatinib 400 mg medicine", "imatinib tablets 400 mg uses", "imatinib 400 mg dosage", "imatinib 400 mg price in india", "imatinib 400 mg brand name" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66644eb5e69b8516f884ea68", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Pantoprazole 40mg Itopride 150mg", "description": "PANTOSTRUM IT\nPantoprazole (40mg), Itopride (150mg)\nPANTOSTRUM IT is a scientifically formulated combination of Pantoprazole 40 mg and Itopride 150 mg, designed to provide effective relief from acid-related gastrointestinal disorders and motility problems. This dual-action medicine not only reduces excess stomach acid but also improves digestive movement, making it an ideal treatment for patients suffering from chronic acidity, gastroesophageal reflux disease (GERD), functional dyspepsia, bloating, nausea, and delayed gastric emptying.\n\nDigestive problems such as heartburn, indigestion, and gas can significantly affect daily comfort and quality of life. PANTOSTRUM IT addresses both the cause (excess acid production) and the symptoms (slow gut movement and discomfort), offering comprehensive gastrointestinal support in a single tablet. This combination is widely prescribed by healthcare professionals for long-term acid control and improved digestion.\n\nComposition\n\nPantoprazole 40 mg\n\nItopride Hydrochloride 150 mg\n\nHow PANTOSTRUM IT Works\n\nPANTOSTRUM IT works through a dual-mechanism approach:\n\nPantoprazole is a proton pump inhibitor (PPI) that reduces the production of stomach acid by blocking the acid-secreting pumps in the stomach lining. This helps heal acid-related damage and prevents irritation of the esophagus and stomach.\n\nItopride is a prokinetic agent that enhances gastrointestinal motility by increasing acetylcholine activity. It helps food move smoothly through the digestive tract, reducing bloating, fullness, nausea, and discomfort.\n\nTogether, these two ingredients provide faster symptom relief and long-lasting digestive comfort.\n\nUses of PANTOSTRUM IT\n\nPANTOSTRUM IT is commonly prescribed for the treatment and management of the following conditions:\n\nGastroesophageal Reflux Disease (GERD)\n\nChronic acidity and heartburn\n\nFunctional dyspepsia\n\nAcid reflux and regurgitation\n\nBloating and abdominal discomfort\n\nNausea and vomiting related to gastric disorders\n\nDelayed gastric emptying\n\nPeptic ulcer disease (as supportive therapy)\n\nIndigestion caused by excess acid secretion\n\nThis combination is particularly beneficial for patients who experience acidity along with symptoms of poor digestion or slow stomach movement.\n\nKey Benefits of PANTOSTRUM IT\n1. Effective Acid Control\n\nPantoprazole 40 mg provides powerful and sustained suppression of gastric acid, reducing irritation, pain, and burning sensations in the chest and stomach.\n\n2. Improves Digestive Motility\n\nItopride 150 mg enhances stomach and intestinal movement, helping relieve bloating, heaviness, and early satiety after meals.\n\n3. Dual Symptom Relief\n\nBy targeting both acid secretion and digestive movement, PANTOSTRUM IT offers more complete relief compared to single-ingredient medicines.\n\n4. Reduces Nausea and Vomiting\n\nImproved gastric emptying helps control nausea and vomiting associated with acid reflux and indigestion.\n\n5. Supports Long-Term Gastrointestinal Health\n\nRegular use under medical supervision helps prevent recurrence of acidity-related complications and improves overall digestive comfort.\n\n6. Well-Tolerated Combination\n\nWhen taken as prescribed, PANTOSTRUM IT is generally well tolerated and suitable for long-term management of chronic gastric disorders.\n\nHow to Take PANTOSTRUM IT\n\nPANTOSTRUM IT should be taken exactly as advised by a healthcare professional. It is usually recommended to take the tablet before meals, preferably in the morning, to achieve maximum acid suppression and digestive support. The tablet should be swallowed whole with water and not crushed or chewed.\n\nPossible Side Effects of PANTOSTRUM IT\n\nLike all medications, PANTOSTRUM IT may cause some side effects, although not everyone experiences them. Most side effects are mild and temporary.\n\nCommon Side Effects\n\nHeadache\n\nDiarrhea or constipation\n\nAbdominal pain\n\nNausea\n\nDizziness\n\nFlatulence\n\nLess Common Side Effects\n\nDry mouth\n\nFatigue\n\nSkin rash or itching\n\nMild increase in liver enzymes\n\nRare Side Effects\n\nAllergic reactions\n\nIrregular bowel movements\n\nProlonged use may affect vitamin B12 absorption (under medical supervision)\n\nIf any severe or persistent side effects occur, medical advice should be sought immediately.\n\nPrecautions and Warnings\n\nUse with caution in patients with liver disorders\n\nNot recommended during pregnancy or breastfeeding unless prescribed\n\nLong-term use should be monitored by a healthcare professional\n\nAvoid alcohol as it may worsen gastric irritation\n\nInform your doctor about other medications to avoid interactions\n\nConclusion\n\nPANTOSTRUM IT is a reliable and effective combination of Pantoprazole 40 mg and Itopride 150 mg, offering comprehensive relief from acid-related and motility-related gastrointestinal disorders. By reducing excess acid production and improving digestive movement, it helps restore comfort, prevents recurrence of symptoms, and supports long-term digestive health.\n\n\n\n\n\n", "price": 185.0, "discountamount": 56.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GERD", "Call", "PPIs", "Email", "drugs", "class", "usage", "relief", "ulcers", "doctor", "dosage", "safety", "Itopride", "efficacy", "WhatsApp", "heartburn", "dyspepsia", "conditions", "indigestion", "information", "sterispharma", "instructions", "sterisonline", "Pantoprazole", "regurgitation", "PANTOSTRUM IT", "gastroparesis", "gastric emptying", "prokinetic agent", "digestive motility", "acid reflux symptoms", "combination medication", "acid-related disorders", "proton pump inhibitors", "stomach acid production", "healthcare professionals", "gastrointestinal motility", "gastrointestinal disorders", "gastroesophageal reflux disease" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1600, "imageuri": "https://productimages.withfloats.com/actual/66644ebd2763378392d54576.png", "tileimageuri": "https://productimages.withfloats.com/tile/66644ebd2763378392d54576.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-08T12:29:41.206Z", "updatedon": "2026-03-14T10:20:28.452Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//pantoprazole-40mg-itopride-150mg/1600", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PANTOSTRUM IT", "category": "GASTROLOGYRANGE", "tags": [ "PANTOSTRUM IT", "Pantoprazole (40mg)", "Itopride (150mg)", "Itopride 150mg uses", "pantoprazole 40mg + itopride 150mg", "Itopride side effects", "Itopride dose", "pantoprazole 40mg itopride 150mg tablets", "pantoprazole itopride combination tablets", "pantoprazole itopride for indigestion", "pantoprazole itopride tablets for gas", "pantoprazole itopride uses and benefits", "pantoprazole itopride for stomach pain", "pantoprazole itopride side effects", "pantoprazole 40mg itopride 150mg price", "pantoprazole itopride tablets price in India", "pantoprazole itopride supplier in India", "pantoprazole itopride gastro medicine", "pantoprazole itopride for functional dyspepsia" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "694919f0de5d3e57a93413a8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "elagolix 150mg tablet", "description": "Eligolux 150 delivers 150mg of elagolix per tablet, formulated as an oral, once-daily option in convenient packs for ongoing therapy. As a non-peptide GnRH receptor antagonist, it selectively suppresses pituitary gonadotropins, reducing ovarian estrogen production without the flare effect of agonists. Ideal for patients with milder symptoms or those prioritizing bone health, this dose minimizes hypoestrogenic risks while targeting endometriotic pain.\n\nTake Eligolux 150 whole with water, with or without food, preferably at the same time daily. Storage requires a cool, dry environment below 30°C, away from children and moisture. Steris Healthcare ensures GMP-compliant manufacturing, making it accessible across India for endometriosis care.\n\nPrimary Uses and Indications\nEligolux 150 primarily treats moderate endometriosis-associated pain, including dysmenorrhea, chronic pelvic discomfort, and dyspareunia. Endometriosis impacts 10% of reproductive-age women, causing ectopic endometrial growth that triggers inflammation and scarring; elagolix 150mg curbs estrogen-driven progression.\n​\nPrescribed when NSAIDs or combined pills prove inadequate, it excels in non-severe cases, allowing prolonged use. Emerging evidence supports its role in heavy menstrual bleeding from fibroids, though primary approval focuses on pain relief. Start therapy within the first week of menses for optimal synchronization.\n​\nMechanism of Action\nElagolix in Eligolux 150 competitively binds GnRH receptors, dose-dependently inhibiting LH/FSH release. This lowers estradiol by 40-60%—less aggressive than 200mg—halting endometrial tissue proliferation outside the uterus. Peak levels hit in 1 hour, with a 4-6 hour half-life supporting steady-state suppression on QD dosing.\n​\nUnlike agonists, no initial hormone surge occurs, preventing worsened pain. Partial estrogen reduction preserves some bone-protective effects, differentiating it from deeper suppression therapies.\n\nKey Benefits\nEligolux 150 shines in clinical responsiveness: phase 3 trials showed 32% dysmenorrhea resolution versus 20% placebo at 6 months, with 50% pain score drops. Quality-of-life gains include better work attendance, sleep, and relationships, per EQ-5D assessments.\n​\nExtended 24-month approval suits long-term control, with amenorrhea in 40-50% of users reducing bleeding volume by 70%. Oral ease beats injectables, enhancing adherence at 85% in studies. Lower BMD impact (0.5-1% loss/year) allows safer continuation versus higher doses.\n\nBenefit\tTrial Data\tPatient Impact\nPain Reduction\t32-50% dysmenorrhea-free \n​\tDaily activity restoration\nBleeding Control\t70% volume drop \n​\tAnemia prevention\nLong-Term Use:\tUp to 24 months \n​\tSustained relief\nQoL Improvement\tEQ-5D gains \n​\tEmotional well-being\nPotential Side Effects\nVasomotor symptoms dominate: hot flashes (20-30%), headaches (17%), and night sweats (10-15%) emerge early but fade. Nausea (8%), insomnia (7%), and mild depression (5%) affect minorities, with a 70% event rate mostly grade 1.\n​\nBMD decline averages -0.9% at the spine after 12 months, monitored via DEXA. Discontinuation hovers at 5-8%.\n\nSide Effect\tIncidence\tMitigation\nHot Flashes\t20-30% \n​\tVentilation, timing\nHeadache\t17% \n​\tAnalgesics\nBMD Loss\t0.9% \n​\tSupplements, scans\nMood Shifts\t5% \n​\tMonitoring\nSerious Risks and Management\nSuicidality (0.1-0.5%) demands baseline psych screening; halt if worsening. Liver enzymes rise in 1%, requiring LFTs at 3/6 months. Rare anaphylaxis or thromboembolism prompts immediate cessation. Avoid in osteoporosis or smokers >35.\n​\n\nDosage Guidelines\n150 mg once daily for up to 24 months in normal/mild liver function; limit to 6 months in moderate impairment (Child-Pugh B). No titration needed; miss a dose? Resume the next day, no doubling. Pair with 1 g calcium/800 IU vitamin D daily.\n​\n\nPrecautions and Contraindications\nPregnancy category X: mandates non-hormonal birth control during and 1 week post-therapy. Screen hepatic/renal function; avoid severe cases. CYP3A interactions (e.g., rifampin reduces efficacy) need dose review. Breastfeeding is contraindicated.\n​\nClinical Evidence and Efficacy\nElaris trials (n=1,689) confirmed superiority: co-primary endpoints met with 75% responder rates for pain. 12-month extensions showed persistent efficacy and low rebound. Versus 200mg, 150mg balances tolerability for moderate pain.\n​\nConclusion\nEligolux 150 empowers women with moderate endometriosis pain through precise, extended hormonal modulation and proven outcomes. Regular physician oversight maximizes safety and efficacy.\n", "price": 700.0, "discountamount": 210.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2252, "imageuri": "https://productimages.withfloats.com/actual/694a2af01e4092f757d90bb5.png", "tileimageuri": "https://productimages.withfloats.com/tile/694a2af01e4092f757d90bb5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-22T10:14:08.773Z", "updatedon": "2026-03-26T05:59:45.544Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//elagolix-150mg-tablet/2252", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ELIGOLUX 150", "category": "GYANECOLOGYRANGE", "tags": [ "elagolix 150mg tablet", "prioritizing bone health.", "endometriotic pain.", "endometrial tissue proliferation outside the uterus.", "Eligolux 150 empowers women with moderate endometriosis pain through precise.", "hormonal modulation and proven outcomes.", "gonadotropins.", "endometriotic pain." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6948f4ee5837f90c86a7e578", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Elagolix 200mg ", "description": "Eligolux200 contains 200 mg of elagolix per tablet and is manufactured by Steris Healthcare Pvt Ltd in India as a prescription medication in packs of 3x10 tablets. Elagolix acts as a potent gonadotropin-releasing hormone (GnRH) receptor antagonist, binding competitively to GnRH receptors in the pituitary gland to rapidly reduce estrogen and progesterone levels without the initial flare-\nup seen in agonists. This mechanism starves endometrial-like tissue outside the uterus of hormonal stimulation, shrinking lesions and easing inflammation.\n\nAdminister Eligolux200 orally, swallowed whole with water, with or without food, typically starting within 7 days of menstrual onset. Standard dosing for severe cases involves 200mg twice daily for up to 6 months, or 150mg once daily extended to 24 months, adjusted by physicians based on tolerance and response. Store in a cool, dry place away from moisture and light, keeping out of children's reach.\n\nPrimary Uses\nEligolux200 targets moderate to severe endometriosis-associated pain, including dysmenorrhea (painful periods), nonmenstrual pelvic pain, and dyspareunia (painful intercourse). Endometriosis affects millions globally, causing tissue similar to the uterine lining to grow ectopically, leading to chronic inflammation, adhesions, and scarring. By dosing flexibly, Eligolux200 suits patients needing stronger suppression for intense symptoms, reducing reliance on opioids or surgery.\n\nClinical trials like Elaris EM-I and EM-II showed 75% dysmenorrhea reduction and 50-60% nonmenstrual pain relief at 6-12 months. It also curbs heavy menstrual bleeding in uterine fibroids, offering dual benefits for overlapping conditions. Physicians prescribe it when first-line NSAIDs or oral contraceptives fail, prioritizing non-invasive symptom control.\n​\n\nKey Benefits\nEligolix in Eligolux200 delivers rapid pain relief, with significant improvements in daily pain scales within 3 months versus placebo. Women report 47% better composite pelvic pain scores, enhancing daily activities, work productivity, and intimacy. Quality-of-life metrics improve consistently over 24 weeks, including reduced fatigue and better emotional well-being.\n​\n\nUnlike injectables, its oral form and dose-dependent estrogen suppression allow titration—lower doses minimize hypoestrogenic effects while higher 200mg dosing tackles severe pain. Studies confirm amenorrhea in 25% of users early on, slashing bleeding days by up to 50%. Long-term data up to 12 months with add-back therapy sustains efficacy, preserving bone health better than monotherapy. Patients regain control, avoiding invasive laparoscopies and reclaiming normalcy.\n​\n\nBenefit\tEvidence from Trials'\tImpact on Patients\nDysmenorrhea Reduction:\t75% at 6 months \n​\tFewer missed workdays\nNonmenstrual Pain Relief:\t50-60% improvement \n​\tEnhanced mobility\nBleeding Control:\t14% bleeding days vs. 24% baseline \n​\tImproved hygiene, anemia prevention\nQuality of Life\tSustained over 24 weeks \n​\tBetter sleep, relationships\nPotential Side Effects\nCommon side effects of Eligolux200 mirror hypoestrogenic states: hot flashes, night sweats, headache, and nausea, each affecting about 10% of users. These often lessen as the body adjusts, with 69.5% overall adverse event rate over 24 weeks, mostly mild. Mood changes like irritability or depression occur less commonly, warranting mood monitoring.\n​\n\nBone mineral density (BMD) loss poses a key concern—200mg twice daily causes -1.5% to -2.4% drops at lumbar spine and hip after 6 months, attenuated with calcium/vitamin D or add-back therapy. Rare serious risks include suicidal thoughts, liver enzyme elevations, or allergic reactions like anaphylaxis. Discontinuation due to events stays low at 4-12%. No deaths are linked directly to treatment in trials.\n​\n\nSide Effect Category\tFrequency\tManagement\nVasomotor (Hot Flashes)\t9.9-10% \n​\tLifestyle cooling, dose adjustment\nNeurologic (Headache)\t9.9% \n​\tHydration, analgesics\nBone Loss\tUp to 2.4% at 6 months \n​\tDEXA scans, supplements\nMood Changes\tLess common \n​\tPsychiatric screening\nPrecautions and Contraindications\nAvoid Eligolux200 in pregnancy (risk of early loss), known osteoporosis, severe hepatic impairment, or with strong OATP1B1 inhibitors like cyclosporine or gemfibrozil. Women of childbearing age need effective non-hormonal contraception during and 28 days post-therapy, as it impairs recognition of pregnancy via amenorrhea. Not for pediatrics under 18 or geriatrics lacking data.\n\nScreen for depression history, liver function, and BMD before starting; monitor quarterly. Drug interactions abound with rifampin (reduces levels) or over 50 others like clarithromycin—inform physicians fully. Breastfeeding lacks safety data; weigh risks. Regular blood/urine tests track efficacy and safety.\n​\n\nDosage Guidelines\nInitiate Eligolux200 at 150mg daily for milder cases, escalating to 200mg BID for dyspareunia or severe pain, max 6 months at higher dose. Miss a dose? Take promptly unless near the next; never double. Duration caps at 24 months total, with liver-adjusted lower dosing. Pair with add-back for extended use to curb BMD loss.\n​\n\nPhysicians tailor based on response: 74-77% complete 6-month trials. Swallow intact; no crushing.\n​\n\nClinical Evidence\nPhase III trials (Elaris EM-I/II) randomized 1689 women, proving both doses superior to placebo for co-primary endpoints of dysmenorrhea and nonmenstrual pain. Open-label extensions to 24 weeks maintained gains. A 12-month study with add-back showed persistent relief and <1% additional BMD loss versus placebo. Real-world use echoes this, positioning Eligolix as first oral GnRH antagonist approved for endometriosis.\n​\n\nVersus relugolix, Eligolix offers comparable pelvic pain reduction with adjustable dosing. Indian brands like Eligolux200 align with global standards.\n​\n\nConclusion\nEligolux200 transforms endometriosis management, delivering substantial pain relief and functional gains through precise hormonal control. Balancing robust benefits against manageable risks like BMD monitoring empowers women toward symptom-free lives. Consult healthcare providers for personalized integration into care plans.\n", "price": 1000.0, "discountamount": 300.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2251, "imageuri": "https://productimages.withfloats.com/actual/694a2b9f403179ac7e958ef6.png", "tileimageuri": "https://productimages.withfloats.com/tile/694a2b9f403179ac7e958ef6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-22T07:36:14.316Z", "updatedon": "2026-03-26T06:00:31.59Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//elagolix-200mg-/2251", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ELIGOLUX 200", "category": "GYANECOLOGYRANGE", "tags": [ "Elagolix Tablets 200mg", "Elagolix acts as a potent gonadotropin-releasing hormone.", "nonmenstrual pelvic pain.", "adhesions, and scarring", "preserving bone health better than monotherapy.", "avoiding invasive laparoscopies and reclaiming normalcy.", "pituitary gland to rapidly reduce estrogen and progesterone.", "tab elagolix 200mg", "elagolix 200mg.", "elagolix.", "elagolix 200.", "elagolix tablets", "elagolix tablets uses.", "elagolix 200 mg price.", "elagolix mechanism of action.", "elagolix 200 mg uses.", "tab elagolixtab elagolix." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68272992e579986392b124bf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Nintedanib 150mg", "description": "NINTEPRIDE 150 is a prescription medication that contains Nintedanib 150 mg, a targeted therapy used primarily in the treatment of idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and certain types of non-small cell lung cancer (NSCLC). It works by slowing the progression of fibrotic diseases, helping to maintain better lung function and improving the patient's quality of life.\n\nKey Ingredient\nNintedanib (150 mg)\nNintedanib is a tyrosine kinase inhibitor that blocks several growth factor receptors responsible for promoting fibrosis and tumor growth. It is an orally administered compound used in chronic and progressive lung conditions.\n\nKey Benefits\nHelps slow down the progression of idiopathic pulmonary fibrosis (IPF).\n\nImproves lung function and delays further decline in lung capacity.\n\nUsed as a treatment for systemic sclerosis-associated interstitial lung disease (SSc-ILD).\n\nBeneficial in certain types of advanced non-small cell lung cancer (NSCLC).\n\nTargets multiple pathways involved in fibrosis and tumor progression.\n\nProvides a convenient oral dosage form for chronic conditions.\n\nHow Does It Work?\nNINTEPRIDE 150 (Nintedanib 150 mg) works by inhibiting multiple receptor tyrosine kinases, including those for platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), and vascular endothelial growth factor (VEGF). These growth factors are responsible for the development and progression of fibrosis and abnormal cell proliferation. By blocking these receptors, Nintedanib helps to:\n\nReduce the formation of scar tissue in the lungs.\n\nDecrease inflammation and tissue remodeling.\n\nInhibit tumor angiogenesis in certain cancer types.\n\nPreserve lung structure and function over time.\n\nDirections for Use\nNINTEPRIDE 150 should be taken orally, twice daily (usually one capsule in the morning and one in the evening).\n\nTake the capsule with food and water to reduce the risk of gastrointestinal side effects.\n\nDo not chew or crush the capsule; swallow it whole.\n\nTake the medication at the same times each day for optimal results.\n\nFollow the dosage and schedule prescribed by your healthcare provider.\n\nIf a dose is missed, skip it and continue with the next scheduled dose. Do not take a double dose.\n\nSide Effects\nNINTEPRIDE 150 may cause some common and serious side effects. It is important to report any persistent or severe symptoms to a healthcare professional.\n\nCommon Side Effects:\n\nDiarrhea\n\nNausea\n\nVomiting\n\nLoss of appetite\n\nWeight loss\n\nAbdominal pain\n\nLiver enzyme elevation\n\nSerious Side Effects:\n\nSevere liver problems\n\nBleeding complications\n\nGastrointestinal perforation\n\nHeart-related issues such as increased blood pressure or myocardial infarction\n\nHypersensitivity reactions including rash, itching, or swelling\n\nRegular liver function monitoring and clinical follow-up are essential while on NINTEPRIDE 150 to ensure safe and effective use.", "price": 987.0, "discountamount": 487.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "nintepride 150", "tumor progression", "capsule swallow", "promoting fibrosis", "nintepride 150nintepride 150", "scheduled dose", "chronic conditions", "lung function", "prescription medication", "ensure safe", "clinical followup", "rash itching", "severe symptoms", "missed skip", "healthcare provider", "schedule prescribed", "time directions", "scar tissue", "growth factors", "lung capacity", "tumor growth", "patients quality", "targeted therapy", "nintedanib 150 mg", "side effects", "gastrointestinal side effects", "orally administered compound", "receptors nintedanib helps", "increased blood pressure", "optimal results follow", "lungs decrease inflammation", "abnormal cell proliferation", "tyrosine kinase inhibitor", "fibrotic diseases helping" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2116, "imageuri": "https://productimages.withfloats.com/actual/682729941972da8c8f537bca.png", "tileimageuri": "https://productimages.withfloats.com/tile/682729941972da8c8f537bca.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-16T12:03:30.781Z", "updatedon": "2026-04-30T08:13:06.722Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//nintedanib-150mg/2116", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NINTEPRIDE 150", "category": "NEPHROLOGYRANGE", "tags": [ "Nintedanib 150 mg", "Nintedanib 150 mg price in India", "Nintedanib 150 mg brands in India", "Nintedanib 150 mg side effects", "nintedanib soft gelatin capsules", "nintedanib soft gelatin capsules uses in hindi", "nintedanib soft gelatin capsules 150 mg", "nintedanib soft gelatin capsules 150 mg", "nintedanib soft gelatin capsules 150mg uses", "nintedanib soft gelatin capsules 150mg price", "rx nintedanib soft gelatin capsules", "nintedanib soft gelatin capsules 150 mg price India", "nintedanib 150 mg twice daily dosage schedule", "buy nintedanib 150 mg soft gelatin capsules online", "nintedanib 150 mg capsules price per strip", "Nindanib 150 soft gelatin capsule buy online" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "668d1d16c923a41fec8ebef0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "N- Acetyl-L-Cysteine U.S.P 150mg and Taurine U.S.P 500mg", "description": "STYLETAURINE ORAL SOLUTION \nN-Acetyl-L-Cysteine U.S.P (150mg) & Taurine U.S.P (500mg)\nOverview\nSTYLETAURINE Oral Solution is a powerful combination of N-Acetyl-L-Cysteine (NAC) 150 mg and Taurine 500 mg, formulated to support respiratory health, enhance liver function, and provide overall antioxidant protection. This solution is designed for those seeking a potent remedy to combat oxidative stress, improve detoxification processes, and support cardiovascular and neurological health.\n\nIngredients and Their Benefits\n\nN-Acetyl-L-Cysteine (NAC) (150 mg)\n\nAntioxidant Protection: NAC is a precursor to glutathione, one of the body's most potent antioxidants. It helps neutralize free radicals, reducing oxidative stress and cellular damage.\nRespiratory Health: NAC acts as a mucolytic agent, breaking down mucus in the airways and making it easier to expel, thus benefiting individuals with chronic respiratory conditions like bronchitis and COPD.\nLiver Detoxification: Enhances the liver's ability to detoxify harmful substances, making it useful in managing liver diseases and in cases of acetaminophen overdose.\nImmune Support: Boosts the immune system, helping the body fend off infections and maintain overall health.\nTaurine (500 mg)\n\nCardiovascular Health: Taurine is essential for maintaining heart health. It helps regulate blood pressure, improves lipid profiles, and supports the function of the heart muscle.\nNeurological Benefits: Supports brain health by stabilizing cell membranes and playing a role in neurotransmission. It may help in conditions like epilepsy and other neurodegenerative diseases.\nEnergy and Muscle Function: Plays a crucial role in muscle contraction and energy production, making it beneficial for athletes and those with muscle disorders.\nAntioxidant Properties: Like NAC, Taurine also exhibits antioxidant effects, protecting cells from oxidative damage.\nUsage and Dosage\nSTYLETAURINE Oral Solution should be taken as directed by a healthcare professional. The typical dosage is one or two tablespoons daily, depending on individual needs and health conditions. It can be mixed with water or juice for easier consumption.\n\nBenefits of STYLETAURINE Oral Solution\n\nEnhanced Respiratory Function: By breaking down mucus and supporting lung health, it improves breathing and alleviates symptoms of respiratory ailments.\nLiver Health Support: Promotes detoxification and protects the liver from damage caused by toxins and free radicals.\nImproved Cardiovascular Health: Regulates blood pressure and supports heart function, contributing to overall cardiovascular wellness.\nBoosted Immune System: Strengthens the immune response, helping the body resist infections and maintain optimal health.\nNeurological Support: Supports cognitive function and neurological health, potentially aiding in the management of neurodegenerative conditions.\nSide Effects\nSTYLETAURINE Oral Solution is generally well-tolerated. However, some individuals may experience mild gastrointestinal discomfort, such as nausea or diarrhea. If these or any other adverse reactions occur, it is important to consult a healthcare provider.\n\nPrecautions and Contraindications\n\nAllergic Reactions: Individuals with known allergies to NAC or Taurine should avoid use.\nMedical Conditions: Patients with pre-existing medical conditions, especially those related to the liver or kidneys, should consult a healthcare provider before starting this supplement.\nPregnancy and Lactation: It is essential to consult a healthcare provider to determine the appropriate dosage and safety for pregnant or breastfeeding women.\nConclusion\nSTYLETAURINE Oral Solution is a versatile and potent supplement that combines the benefits of N-Acetyl-L-Cysteine and Taurine to support respiratory, liver, cardiovascular, and neurological health. Its powerful antioxidant properties help protect against oxidative stress, improve detoxification, and enhance overall well-being. Under the guidance of a healthcare professional, STYLETAURINE Oral Solution can be an integral part of a health regimen aimed at improving quality of life and addressing specific health concerns.\n\n\n", "price": 305.0, "discountamount": 91.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "150 mg", "lung health", "crucial role", "Side Effects", "heart muscle", "brain health", "heart health", "integral part", "free radicals", "potent remedy", "Taurine U.S.P", "typical dosage", "liver function", "heart function", "cell membranes", "lipid profiles", "blood pressure", "health regimen", "optimal health", "liver diseases", "Immune Support", "overall health", "cellular damage", "two tablespoons", "Muscle Function", "mucolytic agent", "immune response", "oxidative damage", "individual needs", "muscle disorders", "oxidative stress", "potent supplement", "energy production", "health conditions", "appropriate dosage", "cognitive function", "easier consumption", "muscle contraction", "harmful substances", "overall well-being", "Allergic Reactions", "respiratory health", "breastfeeding women", "healthcare provider", "potent antioxidants", "neurological health", "antioxidant effects", "Liver Detoxification", "Neurological Support", "respiratory ailments", "powerful combination", "Liver Health Support", "Neurological Benefits", "liver, cardiovascular", "Cardiovascular Health", "Boosted Immune System", "acetaminophen overdose", "healthcare professional", "other adverse reactions", "detoxification processes", "specific health concerns", "STYLETAURINE ORAL SOLUTION", "N- Acetyl-L-Cysteine U.S.P", "existing medical conditions", "neurodegenerative conditions", "Enhanced Respiratory Function", "overall antioxidant protection", "chronic respiratory conditions", "powerful antioxidant properties", "overall cardiovascular wellness", "other neurodegenerative diseases", "mild gastrointestinal discomfort" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1919, "imageuri": "https://productimages.withfloats.com/actual/668d1d1c4944b8c562114ff9.png", "tileimageuri": "https://productimages.withfloats.com/tile/668d1d1c4944b8c562114ff9.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-09T11:20:54.58Z", "updatedon": "2026-04-04T08:14:39.674Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//n-acetyl-l-cysteine-u-s-p-150mg-and-taurine-u-s-p-500mg/1919", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "STYLETAURINE ORAL SOLUTION ", "category": "NEPHROLOGYRANGE", "tags": [ "n-acetylcysteine taurine tablets uses", "n-acetylcysteine & taurine tablets side-effects", "taurine 500 mg+n-acetylcysteine 150 mg brands", "Taurine and Acetylcysteine Tablets brands", "n acetylcysteine and taurine tablets 150mg + 500mg", "Taurine and Acetylcysteine tablets dosage", "n-acetylcysteine & taurine tablets uses in hindi", "n-acetylcysteine and taurine in ckd", "n acetyl cysteine 150 mg taurine 500 mg tablets uses", "nac and taurine combination benefits for liver", "nac taurine tablets price in india", "nac taurine tablets b2b supplier india", "nac taurine tablets lowest price india", "nac taurine best price bulk", "best nac and taurine tablets for liver health in india", "nac taurine combination for fatty liver treatment" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66698530aebebd09001636e4", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "DROTHEPINE 75 ", "description": "DROTHEPINE 75 \nDosulepine (75mg)\nIntroduction\nDROTHEPINE 75 is a medication that contains Dosulepine (75mg), a tricyclic antidepressant used primarily to treat major depressive disorder. It belongs to the class of drugs known as tricyclic antidepressants (TCAs) and works by affecting the balance of certain neurotransmitters in the brain, such as serotonin and norepinephrine, which play a role in mood regulation.\n\nKey Features and Benefits\nDosulepine (75mg)\nAntidepressant Action: Dosulepine is effective in alleviating symptoms of depression, including persistent feelings of sadness, hopelessness, lack of interest in daily activities, and changes in appetite or sleep patterns.\nImproves Mood: By increasing the levels of serotonin and norepinephrine in the brain, Dosulepine helps improve mood and emotional well-being.\nSleep Aid: Some individuals may experience improved sleep quality and reduced insomnia symptoms while taking Dosulepine.\nPain Management: In addition to its antidepressant effects, Dosulepine may also be used to manage certain types of chronic pain, such as neuropathic pain or fibromyalgia.\nAnxiolytic Properties: It can help reduce symptoms of anxiety that often coexist with depression.\nDosage and Administration\nDosage\nStarting Dose: The usual starting dose of Dosulepine is 25mg to 50mg per day, taken in divided doses or as a single dose at bedtime.\nAdjustments: Dosage adjustments may be made by your healthcare provider based on your response to treatment and any side effects experienced.\nMaximum Dose: The maximum recommended dose is typically 150mg per day, although some individuals may require higher doses under medical supervision.\nAdministration\nOral Use: Take DROTHEPINE 75 orally with a full glass of water, preferably at the same time each day to maintain consistent medication levels in the bloodstream.\nDuration: Continue taking Dosulepine as prescribed, even if you start feeling better, to prevent a recurrence of depressive symptoms.\nRegular Follow-ups: Regular follow-up appointments with your healthcare provider are essential to monitor your response to treatment and adjust the dosage as needed.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/drothepine-75-133563", "price": 229.5, "discountamount": 68.85, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "75mg", "role", "lack", "25mg", "50mg", "TCAs", "water", "class", "brain", "EMAIL", "types", "drugs", "balance", "bedtime", "sadness", "anxiety", "changes", "Benefits", "Oral Use", "appetite", "interest", "addition", "response", "Duration", "treatment", "serotonin", "Sleep Aid", "same time", "recurrence", "depression", "full glass", "DROTHEPINE", "Dosulepine", "individuals", "information", "bloodstream", "single dose", "hopelessness", "sterispharma", "fibromyalgia", "sterisonline", "chronic pain", "Introduction", "Key Features", "Maximum Dose", "higher doses", "side effects", "sleep quality", "CALL/WHATSAPP", "divided doses", "norepinephrine", "sleep patterns", "mood regulation", "Pain Management", "daily activities", "neuropathic pain", "neurotransmitters", "insomnia symptoms", "Regular Follow-ups", "Dosage adjustments", "healthcare provider", "usual starting dose", "medical supervision", "depressive symptoms", "persistent feelings", "emotional well-being", "Antidepressant Action", "Administration Dosage", "Anxiolytic Properties", "antidepressant effects", "tricyclic antidepressant", "major depressive disorder", "consistent medication levels", "Regular follow-up appointments" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1826, "imageuri": "https://productimages.withfloats.com/actual/66698534117f82c50b09934e.png", "tileimageuri": "https://productimages.withfloats.com/tile/66698534117f82c50b09934e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-12T11:23:28.642Z", "updatedon": "2026-03-12T10:03:59.311Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//drothepine-75-/1826", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DROTHEPINE 75 ", "category": "NEUROLOGY RANGE", "tags": [ "dosulepin 75 mg uses", "dothip 75 substitute", "dothip 75 side effects", "dothip 75 price", "dosulepin tablet uses in hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6666b270c193a2152467532a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "UDCHOLIC 150", "description": "UDCHOLIC 150\nUrsodeoxycholic Acid / (150mg)\nUDCHOLIC 150 is a medication containing Ursodeoxycholic Acid in a strength of 150mg per dose. Ursodeoxycholic Acid is a bile acid that helps dissolve cholesterol gallstones and improves liver function.\n\nPurpose: Primarily used to treat gallstones, especially cholesterol gallstones, and certain liver conditions like primary biliary cholangitis (PBC) and chronic hepatitis.\n\nMechanism of Action: Ursodeoxycholic Acid works by reducing the production of cholesterol and by increasing the flow of bile in the digestive system, which helps in dissolving gallstones and improving liver function.\n\nDosage and Administration: The usual dosage for UDCHOLIC 150 is determined by the severity of the condition and the patient's response to treatment. It is typically taken orally with water, as directed by a healthcare professional.\n\nPrecautions and Side Effects:\n\nPrecautions: Inform your doctor about any allergies or medical conditions before starting UDCHOLIC 150. Pregnant or breastfeeding women should consult their healthcare provider before using this medication.\nSide Effects: Common side effects may include diarrhea, stomach discomfort, and nausea. Serious side effects are rare but may include allergic reactions or worsening liver function in certain individuals.\nStorage: Store UDCHOLIC 150 at room temperature away from moisture and heat. Keep it out of reach of children.\n\nAlways follow your doctor's instructions and never exceed the prescribed dosage without medical advice. Consult your healthcare provider if you experience any concerning symptoms while taking UDCHOLIC 150. For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/udcholic-150-133817\n\n\n\n\n\n\n", "price": 163.0, "discountamount": 49.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "PBC", "flow", "Call", "dose", "heat", "water", "ORDER", "Email", "150mg", "reach", "nausea", "doctor", "Purpose", "Storage", "patient", "WhatsApp", "response", "severity", "children", "symptoms", "strength", "moisture", "UDCHOLIC", "diarrhea", "Pregnant", "Mechanism", "allergies", "bile acid", "treatment", "concerning", "production", "medication", "Precautions", "information", "individuals", "sterispharma", "instructions", "sterisonline", "usual dosage", "medical advice", "liver function", "Administration", "room temperature", "liver conditions", "digestive system", "chronic hepatitis", "medical conditions", "allergic reactions", "stomach discomfort", "Common side effects", "breastfeeding women", "healthcare provider", "Ursodeoxycholic Acid", "Serious side effects", "cholesterol gallstones", "healthcare professional", "primary biliary cholangitis" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1627, "imageuri": "https://productimages.withfloats.com/actual/6666b272ae2cbfae74c96c2f.png", "tileimageuri": "https://productimages.withfloats.com/tile/6666b272ae2cbfae74c96c2f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-10T07:59:44.383Z", "updatedon": "2026-03-12T10:52:37.547Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//udcholic-150/1627", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "UDCHOLIC 150", "category": "GASTROLOGYRANGE", "tags": [ "UDCHOLIC 150 mg", "Ursodeoxycholic Acid / (150mg)", "Ursodeoxycholic Acid 150mg Uses in Hindi", "Ursodeoxycholic एसिड", "Ursodeoxycholic Acid 150mg dosage", "Ursodeoxycholic Acid 150mg price", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }